Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2016

Open Access 01-12-2016 | Research article

Anxiety and depression in Nepal: prevalence, comorbidity and associations

Authors: Ajay Risal, Kedar Manandhar, Mattias Linde, Timothy J. Steiner, Are Holen

Published in: BMC Psychiatry | Issue 1/2016

Login to get access

Abstract

Background

Anxiety and depression are two important contributors to the global burden of disease. In many developing countries, including Nepal, their prevalences are yet to be assessed.

Methods

A nationwide cross-sectional study was conducted among a representative sample of Nepalese adults aged 18–65 years (N = 2100), selected by multistage random cluster sampling and interviewed at home during unannounced visits. The validated questionnaires included the Hospital Anxiety and Depression Scale (HADS), to detect cases of anxiety (HADS-A), depression (HADS-D) and comorbid anxiety and depression (HADS-cAD), the Eysenck Personality Questionnaire Revised Short Form-Neuroticism (EPQRS-N), and the World Health Organization Quality of Life 8-question scale (WHOQOL-8). Logistic regression analyses were used to explore associations of caseness with four groups of variables: demographic, domicile, substance use, and behavioural and health.

Results

Age- and gender-adjusted point prevalences of HADS-A, HADS-D and HADS-cAD were 16.1, 4.2 and 5.9 % respectively. In a multivariate model, HADS-A was positively associated with urban residence (AOR = 1.82; p < 0.001) and neuroticism (AOR = 1.32; p < 0.001), and negatively with alcohol consumption (AOR = 0.71; p = 0.041). HADS-D was positively associated with marijuana use (AOR = 3.61; p = 0.017) and negatively with quality of life (QoL) (AOR = 0.86; p < 0.001). HADS-cAD was positively associated with widowhood (AOR = 2.71; p = 0.002), urban residence (AOR = 2.37; p = 0.001), living at altitude ≥2000 m (AOR = 2.32; p = 0.002) and neuroticism (AOR = 1.26; p < 0.001), and negatively with alcohol use (AOR = 0.56; p = 0.026) and QoL (AOR = 0.79; p < 0.001).

Conclusion

Depression and anxiety are important mental health conditions in Nepal, and major contributors to public ill health, being very highly prevalent, comorbid and associated with psychosocial burden. They are also linked to the unique topography, habitation and social structure of the country. High prevalence coupled with the disabling nature of these disorders establishes their health-care priority and their importance in national health policy.
Literature
1.
Goldberg D, Huxley P. Common mental disorders: a biosocial model. London: Tavistock/Routledge; 1992.
2.
Risal A. Common mental disorders. Kathmandu Univ Med J. 2011;9(35):213–7.
3.
Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(10):718–79.CrossRefPubMed
4.
Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. doi:10.​1016/​s0140-6736(15)60692-4.CrossRef
5.
6.
7.
Phua HP, Chua AV, Ma S, Heng D, Chew SK. Singapore’s burden of disease and injury 2004. Singapore Med J. 2009;50(5):468–78.PubMed
8.
9.
10.
11.
Patel V, Pereira J, Coutinho L, Fernandes R, Fernandes J, Mann A. Poverty, psychological disorder and disability in primary care attenders in Goa, India. Br J Psychiatry. 1998;172:533–6.CrossRefPubMed
12.
13.
14.
15.
16.
Ahmadvand A, Sepehrmanesh Z, Ghoreishi FS, Afshinmajd S. Prevalence of psychiatric disorders in the general population of Kashan, Iran. Arch Iran Med. 2012;15(4):205-9. doi:012154/aim.006.
17.
Risal A, Manandhar K, Linde M, Koju R, Steiner TJ, Holen A. Reliability and Validity of a Nepali-language Version of the Hospital Anxiety and Depression Scale (HADS). Kathmandu Univ Med J. 2015;50(2):115–24.
18.
19.
20.
21.
22.
23.
24.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRefPubMed
25.
Manandhar K, Risal A, Linde M, Koju R, Steiner TJ, Holen A. Measuring neuroticism in Nepali: Reliability and validity of the Neuroticism Subscale of the Eysenck Personality Questionnaire. Kathmandu Univ Med J. 2015;50(2):156–61.
26.
Eysenck SBG, Eysenck HJ, Barrett P. A revised version of the psychoticism scale. Person Individ Difl. 1985;6(1):21–9.CrossRef
27.
The WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): Development and general psychometric properties. Soc Sci Med. 1998;46:1569–85.CrossRef
28.
Steiner TJ, Gururaj G, Andree C, Katsarava Z, Ayzenberg I, Yu S-Y, et al. Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire. J Headache Pain. 2014;15:3.CrossRefPubMedPubMedCentral
29.
Stovner LJ, Al Jumah M, Birbeck GL, Gururaj G, Jensen R, Katsarava Z, et al. The methodology of population surveys of headache prevalence, burden and cost: Principles and recommendations from the Global Campaign against Headache. J Headache Pain. 2014;15(1):5. doi:10.​1186/​1129-2377-15-5.CrossRefPubMedPubMedCentral
30.
Govenment of Nepal, Ministry of Health and Population, Population Division. Nepal Population Report 2011. Kathmandu: Ministry of Health and Population, Population Division; 2011.
31.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72. doi:10.​1001/​jama.​289.​19.​2560.CrossRefPubMed
32.
33.
Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. 2013;43(3):471–81. doi:10.​1017/​s003329171200151​1.CrossRefPubMed
34.
35.
Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J, et al. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc. 2009;18(1):23–33.CrossRefPubMedPubMedCentral
36.
37.
38.
World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
39.
40.
41.
Hecht H, von Zerssen D, Wittchen HU. Anxiety and depression in a community sample: the influence of comorbidity on social functioning. J Affect Disord. 1990;18(2):137–44.CrossRefPubMed
42.
43.
Patel V, Kirkwood BR, Pednekar S, Pereira B, Barros P, Fernandes J, et al. Gender disadvantage and reproductive health risk factors for common mental disorders in women: a community survey in India. Arch Gen Psychiatry. 2006;63(4):404–13. doi:10.​1001/​archpsyc.​63.​4.​404.CrossRefPubMed
44.
45.
46.
47.
Ministry of Health and Population (MOHP) [Nepal], New ERA, and ICF International Inc. Nepal Demographic and Health Survey 2011. Kathmandu: Ministry of Health and Population, New ERA, and ICF International, Calverton, Maryland; 2012.
48.
Arregui A. Is depression more frequent in the altitude? A pilot study. Rev Med Hered. 1995;6:182–6.
49.
Arregui A, Cabrera J, Leon-Velarde F, Vizcarra D, Umeres H, Acosta R, et al. Chronic mountain sickness, migraine and depression: Causal or fortuitous coexistence? Possible role of hypoxic environment. Rev Med Hered. 1995;6:163–7.
50.
51.
52.
Basnyat B, Litch JA. Medical problems of porters and trekkers in the Nepal Himalaya. Wilderness Environ Med. 1997;8(2):78–81.CrossRefPubMed
53.
54.
Shrestha P. Policy initiatives for drug control in Nepal. Health. 2011;2(2):66–8.
55.
Silverstein B. Gender differences in the prevalence of somatic versus pure depression: a replication. Am J Psychiatry. 2002;159(6):1051–2.CrossRefPubMed
56.
Patel V, Araya R, de Lima M, Ludermir A, Todd C. Women, poverty and common mental disorders in four restructuring societies. Soc Sci Med. 1999;49(11):1461–71.CrossRefPubMed
Metadata
Title
Anxiety and depression in Nepal: prevalence, comorbidity and associations
Authors
Ajay Risal
Kedar Manandhar
Mattias Linde
Timothy J. Steiner
Are Holen
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2016
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-016-0810-0

Other articles of this Issue 1/2016

BMC Psychiatry 1/2016 Go to the issue

Research article

Readmission rates of South Korean psychiatric inpatients by inpatient volumes per psychiatrist

Research article

Ontological security and connectivity provided by pets: a study in the self-management of the everyday lives of people diagnosed with a long-term mental health condition

Research article

Depression treatment decreases healthcare expenditures among working age patients with comorbid conditions and type 2 diabetes mellitus along with newly-diagnosed depression

Research article

Use of an electronic metabolic monitoring form in a mental health service – a retrospective file audit

Research article

Mental health clinician attitudes to the provision of preventive care for chronic disease risk behaviours and association with care provision

Research article

Association between non-compliance with psychiatric treatment and non-psychiatric service utilization and costs in patients with schizophrenia and related disorders